Capula Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,600
Closed -$136K 775
2026
Q1
$136K Sell
1,600
-400
-20% -$35.6K ﹤0.01% 832
2025
Q4
$158K Buy
2,000
+600
+43% +$47K ﹤0.01% 638
2025
Q3
$112K Sell
1,400
-900
-39% -$76.8K ﹤0.01% 709
2025
Q2
$209K Sell
2,300
-300
-12% -$27.4K ﹤0.01% 367
2025
Q1
$244K Buy
+2,600
New +$233K ﹤0.01% 469
2021
Q4
Sell
-106,900
Closed -$8.03M 291
2021
Q3
$8.03M Buy
106,900
+20,600
+24% +$1.64M 0.1% 171
2021
Q2
$6.98M Buy
+86,300
New +$7.06M 0.11% 156
2020
Q3
Sell
-15,000
Closed -$1.1M 164
2020
Q2
$1.1M Buy
+15,000
New +$1.07M 0.04% 243

Other funds holding CL

Capula Management's CL Position: Q2 2026 in Review

Capula Management sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 243 shares — an estimated $20.7K sold.

Capula Management first reported a position in CL in Q4 2019 and held it in 10 quarters. The position peaked at $4.6M in Q3 2021. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Capula Management reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 243 Colgate-Palmolive shares in Q2 2026, an estimated $20.7K.
  • Capula Management first reported a position in Colgate-Palmolive in Q4 2019 and held it in 10 quarters.
  • Capula Management's Colgate-Palmolive position peaked at $4.6M in Q3 2021.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.